CRMAX vs. MASPX

Last updated Jun 4, 2026

CRMAX (CRM Small/Mid Cap Value Fund) and MASPX (BlackRock Advantage SMID Cap Fund, Inc.) are both Mid Cap Blend Equities funds. Over the past 10 years, CRMAX returned 11.15%/yr vs 12.31%/yr for MASPX. Their correlation of 0.92 suggests significant overlap in exposure. CRMAX charges 1.19%/yr vs 0.48%/yr for MASPX.

Performance

CRMAX vs. MASPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CRM Small/Mid Cap Value Fund (CRMAX) and BlackRock Advantage SMID Cap Fund, Inc. (MASPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRMAX achieves a 18.80% return, which is significantly lower than MASPX's 21.36% return. Over the past 10 years, CRMAX has underperformed MASPX with an annualized return of 11.15%, while MASPX has yielded a comparatively higher 12.31% annualized return.

CRMAX

• 1D: 2.92%
• 1M: 9.96%
• YTD: 18.80%
• 6M: 18.25%
• 1Y: 37.66%
• 3Y*: 16.64%
• 5Y*: 7.27%
• 10Y*: 11.15%

MASPX

• 1D: 1.15%
• 1M: 4.84%
• YTD: 21.36%
• 6M: 21.56%
• 1Y: 38.34%
• 3Y*: 20.38%
• 5Y*: 9.46%
• 10Y*: 12.31%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRMAX vs. MASPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRMAX CRM Small/Mid Cap Value Fund	18.80%	3.89%	16.52%	8.77%	-10.82%	26.46%	13.02%	25.69%	-7.84%	13.97%
MASPX BlackRock Advantage SMID Cap Fund, Inc.	21.36%	11.36%	12.11%	18.89%	-15.73%	13.56%	19.79%	28.86%	-6.52%	8.80%

Correlation

The correlation between CRMAX and MASPX is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.91
Correlation (3Y) Calculated over the trailing 3-year period	0.91
Correlation (5Y) Calculated over the trailing 5-year period	0.93
Correlation (10Y) Calculated over the trailing 10-year period	0.90
Correlation (All Time) Calculated using the full available price history since Sep 7, 2004	0.92

The correlation between CRMAX and MASPX has been stable across timeframes, ranging from 0.90 to 0.93 - a consistent structural relationship.

Return for Risk

CRMAX vs. MASPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRMAX

CRMAX Risk / Return Rank: 51
CRMAX Sharpe Ratio Rank: 47
CRMAX Sortino Ratio Rank: 48
CRMAX Omega Ratio Rank: 41
CRMAX Calmar Ratio Rank: 65
CRMAX Martin Ratio Rank: 53

MASPX

MASPX Risk / Return Rank: 71
MASPX Sharpe Ratio Rank: 63
MASPX Sortino Ratio Rank: 58
MASPX Omega Ratio Rank: 52
MASPX Calmar Ratio Rank: 91
MASPX Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRMAX vs. MASPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CRM Small/Mid Cap Value Fund (CRMAX) and BlackRock Advantage SMID Cap Fund, Inc. (MASPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRMAX	MASPX	Difference
Sharpe ratio: Return per unit of total volatility	2.02	2.35	-0.32
Sortino ratio: Return per unit of downside risk	2.92	3.21	-0.28
Omega ratio: Gain probability vs. loss probability	1.35	1.40	-0.05
Calmar ratio: Return relative to maximum drawdown	3.09	4.80	-1.71
Martin ratio: Return relative to average drawdown	10.83	17.83	-7.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRMAX vs. MASPX - Sharpe Ratio Comparison

The current CRMAX Sharpe Ratio is 2.02, which is comparable to the MASPX Sharpe Ratio of 2.35. The chart below compares the historical Sharpe Ratios of CRMAX and MASPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRMAX	MASPX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.02	2.35	-0.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.36	0.45	-0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.54	0.59	-0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.48	0.62	-0.14

Drawdowns

CRMAX vs. MASPX - Drawdown Comparison

The maximum CRMAX drawdown since its inception was -49.36%, smaller than the maximum MASPX drawdown of -63.74%. Use the drawdown chart below to compare losses from any high point for CRMAX and MASPX.

Drawdown Indicators

	CRMAX	MASPX	Difference
Max Drawdown Largest peak-to-trough decline	-49.36%	-63.74%	+14.38%
Max Drawdown (1Y) Largest decline over 1 year	-12.79%	-8.38%	-4.41%
Max Drawdown (3Y) Largest decline over 3 years	-27.73%	-25.41%	-2.32%
Max Drawdown (5Y) Largest decline over 5 years	-27.73%	-26.87%	-0.86%
Max Drawdown (10Y) Largest decline over 10 years	-41.56%	-34.82%	-6.74%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-7.94%	-9.86%	+1.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.64%	2.25%	+1.39%

Volatility

CRMAX vs. MASPX - Volatility Comparison

CRM Small/Mid Cap Value Fund (CRMAX) has a higher volatility of 6.77% compared to BlackRock Advantage SMID Cap Fund, Inc. (MASPX) at 5.03%. This indicates that CRMAX's price experiences larger fluctuations and is considered to be riskier than MASPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRMAX	MASPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.77%	5.03%	+1.74%
Volatility (6M) Calculated over the trailing 6-month period	14.55%	12.65%	+1.90%
Volatility (1Y) Calculated over the trailing 1-year period	19.55%	17.13%	+2.42%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.09%	21.16%	-1.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.74%	20.94%	-0.20%

CRMAX vs. MASPX - Expense Ratio Comparison

CRMAX has a 1.19% expense ratio, which is higher than MASPX's 0.48% expense ratio.

Dividends

CRMAX vs. MASPX - Dividend Comparison

CRMAX's dividend yield for the trailing twelve months is around 4.40%, more than MASPX's 4.20% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRMAX CRM Small/Mid Cap Value Fund	4.40%	5.23%	15.07%	0.64%	6.41%	35.31%	5.86%	2.68%	18.13%	29.30%	2.13%	12.11%
MASPX BlackRock Advantage SMID Cap Fund, Inc.	4.20%	5.09%	1.41%	0.95%	2.04%	40.63%	4.79%	2.73%	27.75%	16.25%	3.40%	3.26%

Frequently Asked Questions

Can I hold both CRMAX and MASPX in my portfolio?

With a correlation of 0.91, CRMAX and MASPX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, CRMAX or MASPX?

CRMAX has higher volatility (6.77%) compared to MASPX (5.03%). In terms of maximum drawdown, CRMAX dropped -49.36% vs MASPX's -63.74%.

Which has better risk-adjusted returns?

MASPX currently has the higher Sharpe Ratio (2.35 vs 2.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.